Caplight Logo









Curebase

Curebase

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.curebase.com

Last Round

Series B

May 5, 2022

Est. Valuation

$2.14M

Total Funding Raised

$57.66M

Momentum Score

25 /100

Company Overview

Curebase is a healthcare technology company that provides a clinical software platform for virtual studies, facilitating end-to-end clinical trial execution by streamlining participant eligibility, enrollment, education, and consent processes.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, Patient Engagement, Medical AI, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Freemium

AI Layer

Application

Keywords

decentralized clinical trialsDCTclinical trial softwareeClinical platformhybrid clinical trialsvirtual clinical trialselectronic data captureEDCeConsentCRO servicescontract research organizationCROelectronic patient-reported outcomesePROpatient recruitmentclinical trial management systemCTMSdigital therapeutics trialsclinical operations

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Curebase Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Curebase Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BMay 5, 2022
Series AApr 22, 2021
SeedOct 18, 2018
AcceleratorAug 22, 2018

Key People

Founding team and executive leadership

Storm Stillman

Chief Executive Officer, Board Member

Executive Team

Tom Lemberg

Founder CEO

Founding Team

Scott Garcia

Chief Financial Officer

Executive Team

Curebase Investors

Notable investors and investment history

InvestorRounds
World Innovation LabSeries B
GaingelsSeries B
Positive SumSeries B
Acrew CapitalSeries B
FJ LabsSeed
BOLD Capital PartnersSeries A, Series B
Y CombinatorAccelerator

Curebase Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Curebase Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Curebase's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range55
Year Founded2017
Last FundingMay 5, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.